摘要
超分子化学使分子通过非共价键与分子复合物结合,纳米药物在进行微创治疗时具有理想的效果,并在合适时机和场所进行药物输送。超分子纳米主要应用于人类健康和疾病,其主要的应用包括诊断和治疗,药物和基因传递,组织工程等。通过组装超双亲分子获取不同结构的纳米粒子,其将成为具有多功能治疗平台并结合成像技术和治疗功能的大有前景的候选技术。包封超分子纳米载体如聚合物胶束,聚合囊泡包封,层层组装等都可运输治疗药物至体内的作用位点并成像。有机和无机分子的混合超分子纳米结构在纳米医学方面的应用具有很大潜力。目前,纳米治疗诊断设备方面的研究进展很快。此外,超分子纳米颗粒具有低毒性,低免疫原性,非致病性及体内可降解性。
关键词: 超分子纳米颗粒,诊断,药物输送,纳米载体,纳米药物,治疗,光动力疗法。
图形摘要
Current Drug Targets
Title:Supramolecular Nanomedicine - An Overview
Volume: 16 Issue: 13
Author(s): Bhupinder Singh Sekhon
Affiliation:
关键词: 超分子纳米颗粒,诊断,药物输送,纳米载体,纳米药物,治疗,光动力疗法。
摘要: Supramolecular chemistry enabling molecules and molecular complexes binding through non-covalent bonds allows nanomedicines to serve their desirable function to deliver drugs at the right time and the right place with minimal invasiveness. Supramolecular nanomedicine is the application of nanosupramolecules to the human health and disease and its main applications include diagnosis and therapy, drug and gene delivery, and tissue engineering. Nanoparticles with different structures obtained by assembling supraamphiphiles are promising candidates for multifunctional therapeutic platforms combining imaging and therapeutic capabilities. Encapsulation in supramolecular nanocarriers such as polymeric micelles, polymeric vesciles, layer-by-layer assembly, and porphysomes has the potential to deliver imaging and therapeutic drugs to the sites of action in the body. Hybrid supramolecular nanostructures of organic and inorganic molecules show promising potential in nanomedicine. Research is progressing towards rapid development on supramolecular nanotheranostic devices. Moreover, supramolecular nanoparticles exhibit low-toxicity, low-immunogenicity, nonpathogenicity, and in vivo degradability.
Export Options
About this article
Cite this article as:
Bhupinder Singh Sekhon , Supramolecular Nanomedicine - An Overview, Current Drug Targets 2015; 16 (13) . https://dx.doi.org/10.2174/1389450115666140804223539
DOI https://dx.doi.org/10.2174/1389450115666140804223539 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Effect of Berberine Chloride in Propyl Thiouracil Induced Thyroidal Dysfunction - A Time Bound Study in Female Rats
Recent Patents on Drug Delivery & Formulation A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
Current Traditional Medicine Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Anti-Cancer Agents in Medicinal Chemistry Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family
Current Drug Therapy uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets Receptor Proteins for Nongenomic Actions of Thyroid Hormone
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) High Survivin Expression in Ductal Carcinoma In Situ (DCIS): A Potential Therapeutic Target
Current Cancer Therapy Reviews Recent Patents on Anti-Cancer Potential of Helenalin
Recent Patents on Anti-Cancer Drug Discovery Caffeic Acid, A Versatile Pharmacophore: An Overview
Mini-Reviews in Medicinal Chemistry Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Current Drug Metabolism Piperine: Medicinal, Analytical and Therapeutics perspective
Current Bioactive Compounds Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
Reviews on Recent Clinical Trials Autofluorescence of Breast Cancer Proteins
Current Metabolomics Treatment and Response to Statins: Gender-related Differences
Current Medicinal Chemistry Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Current HIV Research Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)